W. Eugene Sanders, Christine C. Sanders

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

K. Kümmerer, A. Henninger Clinical Microbiology and Infection

Benchmarking inappropriate empirical antibiotic treatment

Gut bacterial microbiota and obesity

Salvage therapy for multidrug-resistant tuberculosis

Approach to diagnosis of infective endocarditis

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Herpes zoster in non-hospitalized children

K. Kümmerer, A. Henninger Clinical Microbiology and Infection

Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995 Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,

Hydatid disease Clinical Microbiology and Infection

C. Loupa, D. Voyatzoglou, H. Papadaki, G. Kouppari, G. Saroglou

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

P. Davey, C. Pagliari, A. Hayes Clinical Microbiology and Infection

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Trends in antibiotic prescribing in general internal medicine wards: antibiotic use and indication for prescription B. Maraha, M. Bonten, H. Fiolet,

Vector control: a cornerstone in the malaria elimination campaign

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.

Training for the infectious diseases speciality in Norway

F. Grill, P. Muñoz, R. Jofre, E. Bouza

G. Höffken Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

Salvage therapy for multidrug-resistant tuberculosis

Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community R.E. Warren, G. Harvey, R. Carr, D. Ward,

Elements of design: the knowledge on which we build

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Levofloxacin in the treatment of ventilator-associated pneumonia

R. Bitterman, M. Paul, D. Polak, Y. Geffen

Metagenomics and probiotics

Advisory group on Home-based and Outpatient Care (AdHOC): an international consensus statement on non-inpatient parenteral therapy D. Nathwani, J.-J.

M. Aires-de-Sousa Clinical Microbiology and Infection

Effect of antioxidants on the immune response of Helicobacter pylori

Laboratory diagnosis of Clostridium difficile disease

Recent developments in staphylococcal scalded skin syndrome

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

A. Bryskier Clinical Microbiology and Infection

Systematic review of antibiotic consumption in acute care hospitals

Update on antifungal resistance in Aspergillus and Candida

Community-acquired pneumonia: epidemiologic and clinical consideration

Benchmarking inappropriate empirical antibiotic treatment

Training in infectious diseases and tropical medicine in Britain

Clinical infection services—the Leiden experience

Ethan Rubinstein, Itzhak Levy Clinical Microbiology and Infection

Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party Dilip Nathwani, Christopher Conlon Clinical.

Training in infectious diseases—looking to the future

Clinical Microbiology and Infection

Clinical Microbiology and Infection

Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria E. Presterl, F. Daxböck, W. Graninger,

Infection services in the intensive care unit

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Clinical and molecular epidemiology of chromosome-mediated resistance to third- generation cephalosporins in Enterobacter isolates in eastern France D.

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

New oral cephalosporins in pediatric community-acquired infections

In vitro activity of evernimicin and selected antibiotics against methicillin-resistant staphylococci: a 24-country study R. Goering, C.-E. Nord, R.

Carratalà J. Clinical Microbiology and Infection

B.A. Cunha Clinical Microbiology and Infection

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

N. Markeas, G. Stamos, I. Paraskakis, A. Giokas, G. Pistevos

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands J.W. Mouton, A.R. Jansz Clinical.

New patterns of HIV-1 resistance during HAART

L. Blairon, Y. De Gheldre, B. Delaere, A. Sonet, A. Bosly, Y

Joshua P. Metlay, Daniel E. Singer Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party Dilip Nathwani, Christopher Conlon Clinical.

The future of diagnostic bacteriology

Presentation transcript:

Cycling of antibiotics: an approach to circumvent resistance in specialized units of the hospital W. Eugene Sanders, Christine C. Sanders Clinical Microbiology and Infection Volume 1, Issue 4, Pages 223-225 (June 1996) DOI: 10.1016/S1198-743X(15)60278-6 Copyright © 1996 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 The cyclic nature of antibiotic resistance. Clinical Microbiology and Infection 1996 1, 223-225DOI: (10.1016/S1198-743X(15)60278-6) Copyright © 1996 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Example of a cycling scheme for empirical therapy that utilizes β-lactam antibiotics. Each regimen in the cycle is continued for 2 months. Clinical Microbiology and Infection 1996 1, 223-225DOI: (10.1016/S1198-743X(15)60278-6) Copyright © 1996 European Society of Clinical Infectious Diseases Terms and Conditions